73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers characterize mechanism of action of CAR T cells

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci

Researchers characterize mechanism of action of CAR T cells

by H. Lee Moffitt Cancer Center & Research InstituteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe sci
Study shines light on cancer survival and a key gene mutation

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro
Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r

Drug with immunotherapy may provide therapeutic opportunity for patients previously treated for kidney and lung cancer

by University of Texas M. D. Anderson Cancer CenterAung Naing, M.D. Credit: MD Anderson Cancer CenterPegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety r
A chemistry pioneer works to improve a flawed test for a common cancer

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a
Scientists target glioma cancer stem cells, which could improve patient survival

Scientists target glioma cancer stem cells, which could improve patient survival

by Dartmouth-Hitchcock Medical CenterThis photo illustrates the effect of secretion inhibitors on the growth of high-grade glial tumors in mice. The top row show tumors grown in the absence of se

Scientists target glioma cancer stem cells, which could improve patient survival

by Dartmouth-Hitchcock Medical CenterThis photo illustrates the effect of secretion inhibitors on the growth of high-grade glial tumors in mice. The top row show tumors grown in the absence of se
Team finds key to common cancer pathway

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show

Team finds key to common cancer pathway

by Terry Devitt,University of Wisconsin-MadisonThe molecular pathway for the protein p53, commonly associated with many cancers, is illuminated in this micrograph. The p53 - PIP2 complex is show
New promising targeted drug for a rare leukemia

New promising targeted drug for a rare leukemia

by University of HelsinkiBCL-2 family gene expression in blasts across AML types at single cell resolution. (A) UMAP plot of scRNA-seq data of blasts from AML with megakaryoblastic differentiatio

New promising targeted drug for a rare leukemia

by University of HelsinkiBCL-2 family gene expression in blasts across AML types at single cell resolution. (A) UMAP plot of scRNA-seq data of blasts from AML with megakaryoblastic differentiatio
Previous cancer treatment not tied to higher stillbirth rate

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs
Leukemia, lymphoma squarely in sights of new class of drugs

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d
Researchers identify compounds that starve melanoma cancer cells of energy

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a

Researchers identify compounds that starve melanoma cancer cells of energy

by Oregon State UniversityMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Researchers at Oregon State University a
Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T
Study finds that trust in cancer information declined among Black Americans during the pandemic

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand

Study finds that trust in cancer information declined among Black Americans during the pandemic

byTaylor & FrancisCredit: Unsplash/CC0 Public DomainTrust in information given out by the government on cancer fell sharply among the Black population—by almost half—during the COVID-19 pand